<DOC>
	<DOC>NCT00483171</DOC>
	<brief_summary>The purpose of this study is to determine if CP-945,598 is effective in the prevention of weight regain in obese subjects.</brief_summary>
	<brief_title>A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients</brief_title>
	<detailed_description>The CP-945,598 program was terminated on November 3, 2008 due to changing regulatory perspectives on the risk/benefit profile of the CB1 class and likely new regulatory requirements for approval. No safety issues were involved in the termination decision.</detailed_description>
	<criteria>Subject must be overweight (BMI) &gt;/=30 kg/m2, for subjects without co morbidities; &gt;/=27 kg/m2 for subjects with co morbidities Subjects who are willing and able to comply with 8 week Low Calorie Diet, scheduled visits, treatment plan, laboratory tests, and other trial procedures. Participation in a formal weight loss program or significant weight loss (fluctuation &gt;5% of total body weight) in the past 3 months. Subjects with serious medical or psychiatric conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>